BRIEF published on 04/22/2026 at 23:35, 4 months 21 days ago Sanofi and Regeneron Win FDA Approval for Dupixent in Young Children FDA Approval Sanofi Dupixent Regeneron Pediatric Medicine
BRIEF published on 04/22/2026 at 23:35, 4 months 21 days ago Sanofi et Regeneron obtiennent l'approbation de la FDA pour Dupixent chez les jeunes enfants Approbation De La FDA Sanofi Dupixent Regeneron Médecine Pédiatrique
BRIEF published on 04/22/2026 at 23:05, 4 months 21 days ago Green Bridge Metals Clarifies Technical Disclosure Errors Qualified Person Securities Commission Green Bridge Metals Inferred Resources Disclosure Standards
BRIEF published on 04/22/2026 at 23:05, 4 months 21 days ago Green Bridge Metals clarifie les erreurs de divulgation technique Commission Des Valeurs Mobilières Métaux De Pont Vert Personne Qualifiée Ressources Inférées Normes De Divulgation
BRIEF published on 04/22/2026 at 23:00, 4 months 21 days ago Approbation unanime à l'Assemblée générale d'Espace Real Estate Dividende Augmentation De Capital Election Assemblée Stratégie Durable
BRIEF published on 04/22/2026 at 23:00, 4 months 21 days ago Unanimous approval at the Espace Real Estate General Meeting Dividend Capital Increase Election Sustainable Strategy Assembly
BRIEF published on 04/22/2026 at 22:10, 4 months 21 days ago Abivax dévoile des données clés sur l'obefazimod à la Digestive Disease Week Abivax Obefazimod Rectocolite Hémorragique Essais Cliniques Digestive Disease Week
BRIEF published on 04/22/2026 at 22:10, 4 months 21 days ago Abivax unveils key data on obefazimod at Digestive Disease Week Abivax Obefazimod Ulcerative Colitis Clinical Trials Digestive Disease Week
BRIEF published on 04/22/2026 at 22:10, 4 months 21 days ago Abivax to Present Data on Obefazimod at Digestive Disease Week® Abivax Obefazimod Ulcerative Colitis Phase 3 Clinical Trials DDW 2026
BRIEF published on 04/22/2026 at 22:10, 4 months 21 days ago Abivax présentera des données sur l'obéfazimod lors de la Digestive Disease Week® Abivax Obefazimod Rectocolite Hémorragique Essais Cliniques De Phase 3 DDW 2026
Published on 09/12/2026 at 02:35, 1 day 21 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 2 days ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 2 days 2 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 2 days 6 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/13/2026 at 16:45, 6 hours 52 minutes ago Journées européennes du patrimoine : un succès populaire pour l'ouverture exceptionnelle du Siège de la Vaudoise
Published on 09/12/2026 at 17:50, 1 day 5 hours ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 16 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 2 days 1 hour ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 2 days 1 hour ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 07:00, 2 days 16 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days 16 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 3 days 4 hours ago Availability of the 2026 Interim Financial Report
